Company Filing History:
3 out of 389 
1 out of 2,890 
1 out of 1,309 
Years Active: 2000-2008
Title: The Innovations of Stephen L. Swanberg
Introduction
Stephen L. Swanberg is a notable inventor based in Boston, MA (US). He has made significant contributions to the field of biotechnology, particularly in the development of chemokine-related inventions. With a total of 4 patents to his name, Swanberg's work has had a considerable impact on medical research and applications.
Latest Patents
Swanberg's latest patents include innovative advancements in chemokine technology. One of his notable inventions is a chimeric DNA molecule that comprises a sequence encoding a chemokine polypeptide covalently attached to a heterologous polypeptide. This invention not only provides the encoded chimeric polypeptide but also outlines its various uses. Another significant patent involves polynucleotides that encode amino-terminal-modified chemokines, which also includes the encoded amino-terminal-modified chemokines and their applications.
Career Highlights
Throughout his career, Stephen L. Swanberg has worked with prominent organizations such as Genetics Institute, Inc. and The General Hospital Corporation. His experience in these institutions has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Swanberg has had the opportunity to work alongside esteemed colleagues, including Stephen H. Herrmann and Zhijian Lu. These collaborations have further enriched his research and innovation efforts.
Conclusion
Stephen L. Swanberg's contributions to the field of biotechnology through his patents and collaborations highlight his role as a significant inventor. His work continues to influence advancements in medical research and applications.